Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-000051-34Phase 2Completed
Phase 2, randomised, open-label trial of paroxetine in panic disorder (2 arms), sponsored by Italfarmaco. Primary endpoints: Treatment discontinuation, Adverse events and 2 more. Started Nov 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-000051-34.